|
BDs Global Health Initiative recognizes the importance of public-private collaborations in the developing world. As a result, BD regularly collaborates with several leading global health organizations to identify and implement sustainable solutions that will improve patient care in these regions.
International Council of Nurses
The U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR), BD and the
International Council of Nurses (ICN) have entered into a three-year,
public-private partnership valued at $1.25 million to establish a new
Wellness Center for Health Care Workers. The Wellness Center located in
Kampala, Uganda, will be managed by the Uganda National Association of
Nurses and Midwives (UNANM), offering health and support services for
healthcare workers and their families. The goals of this collaboration are
to strengthen the healthcare system and address health worker shortages.
FIND
BD has a long-standing relationship with the Foundation for Innovative
New Diagnostics (FIND). The original agreement was designed to improve
the diagnosis of pulmonary tuberculosis in developing countries. TB is the
leading cause of death for people with AIDS. BD and FIND
established demonstration sites in Africa, Eastern Europe and Asia to
introduce advanced culture technology for rapid diagnosis and drug
sensitivity testing of TB. BD and FIND have since expanded their agreement
to include funding for laboratory strengthening and a pricing agreement
for liquid culture TB diagnostics.
World Economic Forum
BD has provided funding to and is engaged with the World Economic Forum
Global Health Initiative to contribute to the strengthening of health
systems in sub-Saharan Africa. A pilot in Ghana, focused on the issue of
management and leadership development, will seek to leverage the untapped
knowledge and skills of the private sector in this area to benefit the
public sector.
William J. Clinton Foundation
BD entered into an agreement with the William J. Clinton Foundation
to expand accessibility of advanced CD4 cell counting technology for
immune system monitoring of people living with HIV/AIDS. This agreement
resulted in deeply discounted pricing approximately 75% - for developing
world countries compared with developed world pricing. BD also supports
this agreement with training and equipment servicing.
|
